The diacylglycerol lipases: structure, regulation and roles in and beyond endocannabinoid signalling
- PMID: 23108545
- PMCID: PMC3481529
- DOI: 10.1098/rstb.2011.0387
The diacylglycerol lipases: structure, regulation and roles in and beyond endocannabinoid signalling
Abstract
The diacylglycerol lipases (DAGLs) hydrolyse diacylglycerol to generate 2-arachidonoylglycerol (2-AG), the most abundant ligand for the CB(1) and CB(2) cannabinoid receptors in the body. DAGL-dependent endocannabinoid signalling regulates axonal growth and guidance during development, and is required for the generation and migration of new neurons in the adult brain. At developed synapses, 2-AG released from postsynaptic terminals acts back on presynaptic CB(1) receptors to inhibit the secretion of both excitatory and inhibitory neurotransmitters, with this DAGL-dependent synaptic plasticity operating throughout the nervous system. Importantly, the DAGLs have functions that do not involve cannabinoid receptors. For example, 2-AG is the precursor of arachidonic acid in a pathway that maintains the level of this essential lipid in the brain and other organs. This pathway also drives the cyclooxygenase-dependent generation of inflammatory prostaglandins in the brain, which has recently been implicated in the degeneration of dopaminergic neurons in Parkinson's disease. Remarkably, we still know very little about the mechanisms that regulate DAGL activity-however, key insights can be gleaned by homology modelling against other α/β hydrolases and from a detailed examination of published proteomic studies and other databases. These identify a regulatory loop with a highly conserved signature motif, as well as phosphorylation and palmitoylation as post-translational mechanisms likely to regulate function.
Figures



Similar articles
-
Brain regional cannabinoid CB(1) receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice.Eur J Pharm Sci. 2014 Jan 23;51:87-95. doi: 10.1016/j.ejps.2013.08.035. Epub 2013 Sep 3. Eur J Pharm Sci. 2014. PMID: 24012970
-
DAGL-dependent endocannabinoid signalling: roles in axonal pathfinding, synaptic plasticity and adult neurogenesis.Eur J Neurosci. 2011 Nov;34(10):1634-46. doi: 10.1111/j.1460-9568.2011.07831.x. Eur J Neurosci. 2011. PMID: 22103420 Review.
-
Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition.Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):26-33. doi: 10.1073/pnas.1522364112. Epub 2015 Dec 14. Proc Natl Acad Sci U S A. 2016. PMID: 26668358 Free PMC article.
-
Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus.Neuroscience. 2011 Feb 3;174:50-63. doi: 10.1016/j.neuroscience.2010.10.062. Epub 2010 Oct 28. Neuroscience. 2011. PMID: 21035522 Free PMC article.
-
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders.Bioorg Med Chem Lett. 2016 Aug 15;26(16):3831-7. doi: 10.1016/j.bmcl.2016.06.076. Epub 2016 Jun 27. Bioorg Med Chem Lett. 2016. PMID: 27394666 Review.
Cited by
-
DAGLα Inhibition as a Non-invasive and Translational Model of Episodic Headache.Front Pharmacol. 2021 Jan 12;11:615028. doi: 10.3389/fphar.2020.615028. eCollection 2020. Front Pharmacol. 2021. PMID: 33584293 Free PMC article.
-
Differential roles of diacylglycerol lipase (DAGL) enzymes in nicotine withdrawal.Brain Res. 2023 Oct 15;1817:148483. doi: 10.1016/j.brainres.2023.148483. Epub 2023 Jul 11. Brain Res. 2023. PMID: 37442250 Free PMC article.
-
Approaches to Measuring the Activity of Major Lipolytic and Lipogenic Enzymes In Vitro and Ex Vivo.Int J Mol Sci. 2022 Sep 21;23(19):11093. doi: 10.3390/ijms231911093. Int J Mol Sci. 2022. PMID: 36232405 Free PMC article. Review.
-
Interaction between NMDA Receptor- and Endocannabinoid-Mediated Modulation of Nociceptive Synapses.Sci Rep. 2019 Feb 4;9(1):1373. doi: 10.1038/s41598-018-37890-z. Sci Rep. 2019. PMID: 30718662 Free PMC article.
-
Diacylglycerol, phosphatidic acid, and their metabolic enzymes in synaptic vesicle recycling.Adv Biol Regul. 2015 Jan;57:147-52. doi: 10.1016/j.jbior.2014.09.010. Epub 2014 Sep 28. Adv Biol Regul. 2015. PMID: 25446883 Free PMC article. Review.
References
-
- Brose N., Betz A., Wegmeyer H. 2004. Divergent and convergent signaling by the diacylglycerol second messenger pathway in mammals. Curr. Opin. Neurobiol. 14, 328–34010.1016/j.conb.2004.05.006 (doi:10.1016/j.conb.2004.05.006) - DOI - DOI - PubMed
-
- Carrasco S., Merida I. 2007. Diacylglycerol, when simplicity becomes complex. Trends Biochem. Sci. 32, 27–3610.1016/j.tibs.2006.11.004 (doi:10.1016/j.tibs.2006.11.004) - DOI - DOI - PubMed
-
- Prescott S. M., Majerus P. W. 1983. Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate. J. Biol. Chem. 258, 764–769 - PubMed
-
- Allen A. C., Gammon C. M., Ousley A. H., McCarthy K. D., Morell P. 1992. Bradykinin stimulates arachidonic acid release through the sequential actions of an sn-1 diacylglycerol lipase and a monoacylglycerol lipase. J. Neurochem. 58, 1130–113910.1111/j.1471-4159.1992.tb09372.x (doi:10.1111/j.1471-4159.1992.tb09372.x) - DOI - DOI - PubMed
-
- Kennerly D. A., Sullivan T. J., Sylwester P., Parker C. W. 1979. Diacylglycerol metabolism in mast cells: a potential role in membrane fusion and arachidonic acid release. J. Exp. Med. 150, 1039–104410.1084/jem.150.4.1039 (doi:10.1084/jem.150.4.1039) - DOI - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources